FDA approves osimertinib with chemotherapy for EGFR-mutated non-small cell lung cancer

FDA approves osimertinib with chemotherapy for EGFR-mutated non-small cell lung cancer

http://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-osime...

Source: FDA Center for Drug Evaluation and Research - What's New - February 16, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

More News: Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Lung Cancer | Non-Small Cell Lung Cancer